Clinical Trial Tests Nivolumab for Patients with Rare Brain and Spine Cancers
This phase 2 clinical trial, led by Dr. Marta Penas-Prado, is for adults (age 18 or above) with rare brain and spine tumors. The goal is to test whether stimulating the immune system using the drug nivolumab can shrink these tumors or increase the time it takes for them to grow or spread.
Questions? Contact the NCI Neuro-Oncology Branch at (240) 760-6010 or [email protected].
Learn more about the trial: https://www.cancer.gov/research/parti...
Watch this video with audio descriptions: • Audio Described: Clinical Trial Tests...
Watch video Clinical Trial Tests Nivolumab for Patients with Rare Brain and Spine Cancers online, duration hours minute second in high quality that is uploaded to the channel National Cancer Institute 05 August 2024. Share the link to the video on social media so that your subscribers and friends will also watch this video. This video clip has been viewed 1,362 times and liked it 9 visitors.
